Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 05, 2006 02:39 ET | Source: Epigenomics AG

Epigenomics AG Successfully Completes First Step Towards Lung Cancer Screening Test Development

-- Many novel candidate DNA methylation biomarkers discovered -- Candidate biomarkers broadly applicable to major subtypes of lung cancer -- Clinical validation studies in blood to begin...
August 17, 2006 18:57 ET | Source: Epigenomics AG

Epigenomics Announces Change in the Executive Board

BERLIN, Aug. 17, 2006 (PRIMEZONE) -- The Supervisory Board of Epigenomics AG and the Chief Executive Officer and founder Alexander Olek have unanimously agreed that his service contract as well as his...
August 07, 2006 09:34 ET | Source: Epigenomics AG

Epigenomics AG Enters Into Agreement With Johnson & Johnson Pharmaceutical Research & Development, L.L.C

BERLIN, Aug. 7, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) has entered into an R&D collaboration with Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)...
August 03, 2006 09:12 ET | Source: Epigenomics AG

Epigenomics AG Reports Second Quarter 2006 Financial Results

BERLIN, Aug. 3, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial results for the...
July 21, 2006 09:55 ET | Source: Epigenomics AG

Hugin Ad Hoc Announcement According to Section 15 WpHG: Capital Increase: Epigenomics AG: Epigenomics AG Decides Capital Increase -- Affymetrix Signs for New Shares

BERLIN, July 21, 2006 (PRIMEZONE) -- Epigenomics' Management Board decided with the approval of the Supervisory Board on July 20, 2006, to increase the signed capital of the company by making partial...
July 05, 2006 09:49 ET | Source: Epigenomics AG

Epigenomics AG Presents New Clinical Data on Colorectal Cancer Screening Markers

BERLIN and SEATTLE, July 5, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, is presenting new...
June 27, 2006 12:24 ET | Source: Epigenomics AG

Hugin Ad hoc Announcement According to No. 15 WpHG: License: Epigenomics AG: Epigenomics AG and Affymetrix Announce Strategic Diagnostics Platform Agreement

SANTA CLARA, Calif., BERLIN and SEATTLE, June 27, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation,...
June 26, 2006 13:28 ET | Source: Epigenomics AG

Epigenomics AG and Wellcome Trust Sanger Institute Release Epigenetic Data on the First 3 Chromosomes

BERLIN and SEATTLE, June 26, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, and the Wellcome Trust...
June 08, 2006 15:09 ET | Source: Epigenomics AG

Epigenomics AG Announces Research Collaboration with Stanford University

BERLIN, Germany and SEATTLE, June 8, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that the company has...
May 16, 2006 09:16 ET | Source: Epigenomics AG

Epigenomics AG Announces Continuation of Pharmaceutical Biomarker Research Collaboration with AstraZeneca in the Field of Oncology

BERLIN and SEATTLE, May 16, 2006 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that the...